CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


11-August-2015
Cerilliant Introduces New Multi-component Solution Mixes for Drug Interference Testing

Interference Mix 4, 5-100 I-026
5-100 µg/mL in Methanol

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs alprazolam; cimetidine; citalopram HBr; clonazepam; clopidogrel bisulfate; dextromethorphan; fluconazole; hydrochlorothiazide; lamotrigine; L-thyroxine; methylphenidate HCl; and omeprazole. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory's analytical methods.

Interference Mix 7, 50-100 I-029
50-100 µg/mL (as free base) in Methanol

This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory's analytical methods. This multi-component solution standard contains the routinely monitored over-the-counter (OTC) and prescription drugs montelukast sodium salt, pioglitazone hydrochloride, prednisolone, prednisone, procainamide HCl and simvastatin. 



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.


All New Product Announcements


© 2020 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn